# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 165

Extent: E+W+S+N.I.

In regulation 209 (amendment of regulation 270 (non-compliance with requirements of this Part)) for “for “marketing authorisation” to the end substitute “for “marketing authorisation,” substitute “ UK marketing authorisation, EU marketing authorisation, ”.

---
Source: https://www.legislation.gov.uk/uksi/2020/1488/schedule/2/paragraph/165 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-165
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

